Empower Your Fight Against Mesothelioma
Mesothelioma demands precise handling and expert intervention. Learn more about the mechanics of this asbestos-related disease and how preserving your living tissue accelerates your access to clinical and immunologic breakthroughs.
Talk to a Care SpecialistWhat is Mesothelioma?
Mesothelioma is a rare, aggressive cancer developing in the thin layer of tissue covering the majority of your internal organs (the mesothelium). The most common type is pleural mesothelioma, which affects the tissue surrounding the lungs.
Almost exclusively caused by past asbestos exposure—often presenting decades after the actual contact—these tumors tend to coat organs in a tough, unyielding rind of cancer cells rather than forming neat, easily removable masses.
What Does Mesothelioma Do?
The cancer encases pulmonary pathways, significantly inhibiting their movement and fluid dynamics.
- Breathing Restriction: The thick "rind" of the tumor squeezes the lung, preventing it from expanding properly and causing profound shortness of breath and chest pain.
- Fluid Accumulation: It frequently generates pleural effusions—massive buildups of fluid between the lung and chest wall that require mechanical draining.
- Complex Surgical Landscapes: Because the cancer grows along the linings rather than forming isolated lumps, it stubbornly resists traditional surgical clearance.
Current Treatment Options
Extensive Resection
Highly complex procedures like Extrapleural Pneumonectomy (EPP) aiming to strip away the lining and affected tissue in an attempt to surgically cure or vastly debulk.
Dual Immunotherapy
Often becoming the first-line choice over chemotherapy, drugs fighting the disease via immune activation have become standard for non-surgical cases.
Multimodal Regimens
Combining heavy surgical debulking with heated intraoperative chemotherapy (HIPEC for peritoneal types) and systemic radiation.
Why Bank Your Living Mesothelioma Tissue?
Because typical mesothelioma blankets the organs, standard surgery rarely clears it completely, and the disease routinely returns faster than standard meds can stop it. By biobanking your tissue alive through KernisHealth, you allow experts to model your precise immune response.
Immunotherapy Modeling
Living models of your tumor act as a testbed for novel immunotherapeutic cocktails, ensuring interventions truly activate your specific T-cells.
Virotherapy Readiness
A promising research avenue for mesothelioma is using engineered viruses to attack the tumor. Cultivating live tissue keeps this futuristic door firmly open.
Clinical Trial Readiness
Immediate entry into trials investigating highly specialized genetic mutations mapping asbestos damage requires holding viable, unaltered biological profiles.
Future-Proofing Your Care
Should initial debulking and standard treatments eventually face resistance, oncologists have a secure reserve of your tumor geometry to consult and analyze.